BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 10419882)

  • 1. Long-term correction of phagocyte NADPH oxidase activity by retroviral-mediated gene transfer in murine X-linked chronic granulomatous disease.
    Dinauer MC; Li LL; Björgvinsdóttir H; Ding C; Pech N
    Blood; 1999 Aug; 94(3):914-22. PubMed ID: 10419882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retroviral-mediated gene transfer of gp91phox into bone marrow cells rescues defect in host defense against Aspergillus fumigatus in murine X-linked chronic granulomatous disease.
    Björgvinsdóttir H; Ding C; Pech N; Gifford MA; Li LL; Dinauer MC
    Blood; 1997 Jan; 89(1):41-8. PubMed ID: 8978275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Third-generation, self-inactivating gp91(phox) lentivector corrects the oxidase defect in NOD/SCID mouse-repopulating peripheral blood-mobilized CD34+ cells from patients with X-linked chronic granulomatous disease.
    Roesler J; Brenner S; Bukovsky AA; Whiting-Theobald N; Dull T; Kelly M; Civin CI; Malech HL
    Blood; 2002 Dec; 100(13):4381-90. PubMed ID: 12393624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correction of respiratory burst activity in X-linked chronic granulomatous cells to therapeutically relevant levels after gene transfer into bone marrow CD34+ cells.
    Becker S; Wasser S; Hauses M; Hossle JP; Ott MG; Dinauer MC; Ganser A; Hoelzer D; Seger R; Grez M
    Hum Gene Ther; 1998 Jul; 9(11):1561-70. PubMed ID: 9694155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-level reconstitution of respiratory burst activity in a human X-linked chronic granulomatous disease (X-CGD) cell line and correction of murine X-CGD bone marrow cells by retroviral-mediated gene transfer of human gp91phox.
    Ding C; Kume A; Björgvinsdóttir H; Hawley RG; Pech N; Dinauer MC
    Blood; 1996 Sep; 88(5):1834-40. PubMed ID: 8781441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retroviral vector integration in post-transplant hematopoiesis in mice conditioned with either submyeloablative or ablative irradiation.
    Sadat MA; Dirscherl S; Sastry L; Dantzer J; Pech N; Griffin S; Hawkins T; Zhao Y; Barese CN; Cross S; Orazi A; An C; Goebel WS; Yoder MC; Li X; Grez M; Cornetta K; Mooney SD; Dinauer MC
    Gene Ther; 2009 Dec; 16(12):1452-64. PubMed ID: 19657370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term high-level reconstitution of NADPH oxidase activity in murine X-linked chronic granulomatous disease using a bicistronic vector expressing gp91phox and a Delta LNGFR cell surface marker.
    Sadat MA; Pech N; Saulnier S; Leroy BA; Hossle JP; Grez M; Dinauer MC
    Hum Gene Ther; 2003 May; 14(7):651-66. PubMed ID: 12804147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical correction of X-CGD by a novel chimeric promoter regulating high levels of transgene expression in myeloid cells.
    Santilli G; Almarza E; Brendel C; Choi U; Beilin C; Blundell MP; Haria S; Parsley KL; Kinnon C; Malech HL; Bueren JA; Grez M; Thrasher AJ
    Mol Ther; 2011 Jan; 19(1):122-32. PubMed ID: 20978475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variable correction of host defense following gene transfer and bone marrow transplantation in murine X-linked chronic granulomatous disease.
    Dinauer MC; Gifford MA; Pech N; Li LL; Emshwiller P
    Blood; 2001 Jun; 97(12):3738-45. PubMed ID: 11389011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene therapy of chronic granulomatous disease.
    Grez M; Becker S; Saulnier S; Knöss H; Ott MG; Maurer A; Dinauer MC; Hoelzer D; Seger R; Hossle JP
    Bone Marrow Transplant; 2000 May; 25 Suppl 2():S99-104. PubMed ID: 10933200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient retroviral transduction of human bone marrow progenitor and long-term culture-initiating cells: partial reconstitution of cells from patients with X-linked chronic granulomatous disease by gp91-phox expression.
    Porter CD; Parkar MH; Collins MK; Levinsky RJ; Kinnon C
    Blood; 1996 May; 87(9):3722-30. PubMed ID: 8611697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Missense mutations in the gp91-phox gene encoding cytochrome b558 in patients with cytochrome b positive and negative X-linked chronic granulomatous disease.
    Kaneda M; Sakuraba H; Ohtake A; Nishida A; Kiryu C; Kakinuma K
    Blood; 1999 Mar; 93(6):2098-104. PubMed ID: 10068684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p22-phox-deficient chronic granulomatous disease: reconstitution by retrovirus-mediated expression and identification of a biosynthetic intermediate of gp91-phox.
    Porter CD; Parkar MH; Verhoeven AJ; Levinsky RJ; Collins MK; Kinnon C
    Blood; 1994 Oct; 84(8):2767-75. PubMed ID: 7919388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. X-linked chronic granulomatous disease: correction of NADPH oxidase defect by retrovirus-mediated expression of gp91-phox.
    Porter CD; Parkar MH; Levinsky RJ; Collins MK; Kinnon C
    Blood; 1993 Oct; 82(7):2196-202. PubMed ID: 8400270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reconstitution of NADPH oxidase activity in human X-linked chronic granulomatous disease myeloid cells after stable gene transfer using a recombinant adeno-associated virus 2 vector.
    Li LL; Dinauer
    Blood Cells Mol Dis; 1998 Dec; 24(4):522-38. PubMed ID: 9880243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Four novel mutations in the gene encoding gp91-phox of human NADPH oxidase: consequences for oxidase assembly.
    Leusen JH; Meischl C; Eppink MH; Hilarius PM; de Boer M; Weening RS; Ahlin A; Sanders L; Goldblatt D; Skopczynska H; Bernatowska E; Palmblad J; Verhoeven AJ; van Berkel WJ; Roos D
    Blood; 2000 Jan; 95(2):666-73. PubMed ID: 10627478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Gene therapy for inherited diseases using heamatopoietic stem cells--gene therapy for patients with chronic granulomatous disease].
    Nunoi H; Ishibashi F
    Hum Cell; 1999 Sep; 12(3):103-8. PubMed ID: 10695016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-Clinical Efficacy and Safety Studies on G1XCGD, a Lentiviral Vector for Ex Vivo Gene Therapy of X-Linked Chronic Granulomatous Disease.
    Brendel C; Rothe M; Santilli G; Charrier S; Stein S; Kunkel H; Abriss D; Müller-Kuller U; Gaspar B; Modlich U; Galy A; Schambach A; Thrasher AJ; Grez M
    Hum Gene Ther Clin Dev; 2018 Jun; 29(2):69-79. PubMed ID: 29664709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutation at histidine 338 of gp91(phox) depletes FAD and affects expression of cytochrome b558 of the human NADPH oxidase.
    Yoshida LS; Saruta F; Yoshikawa K; Tatsuzawa O; Tsunawaki S
    J Biol Chem; 1998 Oct; 273(43):27879-86. PubMed ID: 9774399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simian immunodeficiency virus lentivector corrects human X-linked chronic granulomatous disease in the NOD/SCID mouse xenograft.
    Naumann N; De Ravin SS; Choi U; Moayeri M; Whiting-Theobald N; Linton GF; Ikeda Y; Malech HL
    Gene Ther; 2007 Nov; 14(21):1513-24. PubMed ID: 17728796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.